Introduction to the CANWARD Study (2007-2009)

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 3, 2011, Pages 289-290

  Hoban, Daryl J ^a   Zhanel, George G ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; CEFTOBIPROLE; DALBAVANCIN; EXTENDED SPECTRUM BETA LACTAMASE; TELAVANCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CANADA; CANADIAN WARD SURVEILLANCE STUDY; CLINICAL LABORATORY; CLINICAL PROTOCOL; DEMOGRAPHY; DRUG MECHANISM; EDITORIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROORGANISM DETECTION; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOCIAL PROBLEM; SYMPOSIUM; SYSTEM ANALYSIS;

ACINETOBACTER BAUMANNII; BACTERIAL INFECTIONS; CANADA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITALS; HUMANS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 79951870210     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.10.024     Document Type: Editorial

References (17)

1. Adam H., DeCorby M., Rennie R., Karlowsky J., Hoban D.J., Canadian Antimicrobial Resistance Alliance (CARA), Zhanel G.G. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD Study (2007-2009). Diagn. Microbiol. Infect. Dis. 2011, 69:307-313.
2. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N. Engl. J. Med. 2009, 360:439-443.
3. Garcia M.G., De la Torre M.A., Morales G., Peláez B., Tolón M.J., Domingo S., Candel F.J., Andrade R., Arribi A., Garcia N., Sagasti F.M., Fereres J., Picazo J. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010, 303:2260-2264.
4. Karlowsky J.A., Adam H.J., Poutanen S.M., Hoban D.J., Canadian Antimicrobial Resistance Alliance (CARA), Zhanel G.G. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: CANWARD 2007-2009. Diagn. Microbiol. Infect. Dis. 2011, 69:342-347.
5. Kennedy A.D., DeLeo F.R. Epidemiology and virulence of community-associated MRSA. Clin. Microbiol. Newsl. 2009, 31:153-160.
6. Lagacé-Wiens P.R.S., Simner P.J., Forward K., Tailor F., Adam H., DeCorby M., Karlowsky J., Hoban D.J., Canadian Antimicrobial Resistance Alliance (CARA), Zhanel G.G. Analysis of 3786 in- and out-patient Escherichia coli isolates from across Canada-results from the CANWARD 2007-2009 study. Diagn. Microbiol. Infect. Dis. 2011, 69:314-319.
7. Lewis I.I.J.S., Herrera M., Wicks B., Patterson J.E., Jorgensen J.H. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant esbl isolated in a U.S. health care system. Antimicrob. Agents Chemother. 2007, 51:4015-4021.
8. McCracken M., Mataseje L., Loo V., Walkty A., Adam H., Hoban D.J., Zhanel G.G., Canadian Antimicrobial Resistance Alliance (CARA), Mulvey M. Characterization of Acinetobacter baumannii and Pseudomonas aeruginosa in Canada: results from the CANWARD study, 2007-2009. Diagn. Microbiol. Infect. Dis. 2011, 69:335-341.
9. Nichol K.A., Adam H.J., Hussain Z., Mulvey M.R., Thompson K., Kost S., Mataseje L., Lagacé-Wiens P.R.S., Hoban D.J., Canadian Antimicrobial Resistance Alliance (CARA), Zhanel G.G. Comparison of community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus in Canada: results from CANWARD 2007-2009. Diagn. Microbiol. Infect. Dis. 2011, 69:320-325.
10. Perez F., Endimiani A., Hujer K.M., Bonomo R.A. The continuing challenge of ESBLs. Curr. Opin. Pharmacol. 2007, 7:459-469.
11. Pitout J.D.D., Laupland K.V. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Inf. Dis. 2008, 8:159-166.
12. Qi C., Pilla V., Yu J.H., Reed K. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum β-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn. Microbiol. Infect. Dis. 2010, 67:87-91.
13. Queenan A.M., Bush K. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 2007, 20:440-458.
14. Simner P.J., Zhanel G.G., Pitout J., Tailor F., McCracken M., Mulvey M.R., Lagacé-Wiens P.R.S., Adam H.J., Canadian Antimicrobial Resistance Alliance (CARA), Hoban D.J. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli isolated in Canadian hospitals from 2007 to 2009: results of the CANWARD study. Diagn. Microbiol. Infect. Dis. 2011, 69:326-334.
15. Walkty A., Adam H., Laverdiere M., Hoban D.J., Canadian Antimicrobial Resistance Alliance (CARA), Zhanel G.G. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens isolated from patients in Canadian hospitals in 2007-2009. Diagn. Microbiol. Infect. Dis. 2011, 69:348-355.
16. Yang Q., Wang H., Sun H., Chen H., Xu Y., Chen M. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillances in China. Antimicrob. Agents Chemother. 2010, 54:573-577.
17. Zhanel G.G., Adam H., Low D., Blondeau J., DeCorby M., Karlowsky J., Canadian Antimicrobial Resistance Alliance (CARA), Hoban D.J. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: CANWARD study 2007-2009. Diagn. Microbiol. Infect. Dis. 2011, 69:291-306.